Related references
Note: Only part of the references are listed.Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P. Grimison et al.
ANNALS OF ONCOLOGY (2020)
Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care
Kristine A. Donovan et al.
JOURNAL OF PALLIATIVE MEDICINE (2019)
Cannabis Use among Patients in a Rural Academic Palliative Care Clinic
Matthew McEwen Wilson et al.
JOURNAL OF PALLIATIVE MEDICINE (2019)
Provider Perspectives on Use of Medical Marijuana in Children With Cancer
Prasanna Ananth et al.
PEDIATRICS (2018)
Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study
Ilana M. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cannabis Use Among Patients at a Comprehensive Cancer Center in a State With Legalized Medicinal and Recreational Use
Steven A. Pergam et al.
CANCER (2017)
Tree-in-Bloom: Severe Acute Lung Injury Induced by Vaping Cannabis Oil
Tao He et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Addressing Tobacco Use in Patients With Cancer: A Survey of American Society of Clinical Oncology Members
Graham W. Warren et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
